AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31673207 — intervention group
Group type: COMPARATOR
Intervention: Conventional hypofractionated palliative radiotherapy (30 Gy/10 fractions/2 weeks)
Number of subjects: 50
Study 28433753 — intervention group
Group type: EXPERIMENTAL
Intervention: Computational image analysis of optical coherence tomography (OCT) data
Number of subjects: 629
Study 24583959 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive aid in the form of a best practice guideline for disclosure and apology
Number of subjects: 60
Study 24583959 — intervention group
Group type: COMPARATOR
Intervention: Control group (only given time to plan)
Number of subjects: 60
Study 24549818 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg simvastatin
Number of subjects: 133
Study 24549818 — intervention group
Group type: EXPERIMENTAL
Intervention: 10, 20, 30, 40 to 80 mg simvastatin (crossover study)
Number of subjects: 133
Study 22230731 — intervention group
Group type: EXPERIMENTAL
Intervention: Leicester Cough Questionnaire (LCQ)
Number of subjects: 54
Study 19212822 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, ketogenic diet (LCKD)
Number of subjects: 119
Study 19212822 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 119
Study 17956584 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% IVIg ready‐to‐use solution
Number of subjects: 14
Study 17956584 — intervention group
Group type: COMPARATOR
Intervention: 6% IVIg lyophilized solution
Number of subjects: 14
Study 15708052 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 195
Study 15708052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 12230338 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-setting intervention
Number of subjects: 0
Study 12230338 — intervention group
Group type: COMPARATOR
Intervention: Social support control
Number of subjects: 0
Study 12230338 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 10217585 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (1.0 microg) coadministered with influenza vaccine
Number of subjects: 175
Study 10217585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 7574828 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunscreen plus UVB (SPF 29 sunscreen containing octyl methoxycinnamate, oxybenzone, and octyl salicylate) followed by three minimal erythema doses of UVB irradiation.
Number of subjects: 29
Study 7574828 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB group (three minimal erythema doses of UVB irradiation without sunscreen).
Number of subjects: 29
Study 7574828 — intervention group
Group type: COMPARATOR
Intervention: No-UVB group (control group with no prior exposure to UVB).
Number of subjects: 29
Study 2710641 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine divitabs (sustained-release formulation)
Number of subjects: 20
Study 2710641 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine normal formulation (ordinary tablets)
Number of subjects: 20
Study 2710641 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine divitabs
Number of subjects: 20
Study 7015139 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen combined with L‐phenylalanine mustard and 5‐fluorouracil
Number of subjects: 0
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV vaccine with 85% efficacy
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV vaccine with 50% efficacy
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: Altruistic attitudes
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational attainment
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine-related social concerns
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: Altruism
Number of subjects: 137
Study 31522806 — intervention group
Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 137
Study 28714882 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20 drops of Vigantol oil, 1904 IU/d)
Number of subjects: 59
Study 28714882 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil (medium chain triglycerides)
Number of subjects: 59
Study 28714882 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 59
Study 26822091 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 27
Study 26822091 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise recovery
Number of subjects: 27
Study 26822091 — intervention group
Group type: COMPARATOR
Intervention: Insulin stimulation
Number of subjects: 27
Study 25108506 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard online weight loss program (n=94)
Number of subjects: 289
Study 25108506 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced online weight loss program with personalized feedback (n=98)
Number of subjects: 289
Study 25108506 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n=97)
Number of subjects: 289
Study 25108506 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced online program (n=98)
Number of subjects: 289
Study 25108506 — intervention group
Group type: EXPERIMENTAL
Intervention: ARFS and sub-scale scores (fruit, meat, wholegrain, dairy, water)
Number of subjects: 289
Study 22858133 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative muscle activation patterns of the quadriceps and gastrocnemius muscle groups during gait
Number of subjects: 37
Study 22858133 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged activation of the vastus medialis muscle and higher activation of the lateral gastrocnemius muscle during early stance
Number of subjects: 37
Study 20352320 — intervention group
Group type: EXPERIMENTAL
Intervention: Microenterprise intervention (tailoring of canvas bags)
Number of subjects: 100
Study 20352320 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 18998062 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous needle punctures and aspiration of calcareous deposits
Number of subjects: 81
Study 18998062 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided punctures only
Number of subjects: 81
Study 15800784 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F‐fluorodeoxyglucose (FDG) PET
Number of subjects: 30
Study 15800784 — intervention group
Group type: EXPERIMENTAL
Intervention: Voxel-based morphometry (VBM) analysis
Number of subjects: 30
Study 15800784 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 30
Study 12090782 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol 9 microg
Number of subjects: 20
Study 12090782 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol 18 microg
Number of subjects: 20
Study 12090782 — intervention group
Group type: COMPARATOR
Intervention: salbutamol 100 microg
Number of subjects: 20
Study 12090782 — intervention group
Group type: COMPARATOR
Intervention: salbutamol 200 microg
Number of subjects: 20
Study 10528871 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐HMPAO uptake
Number of subjects: 25
Study 10528871 — intervention group
Group type: COMPARATOR
Intervention: Neuropsychological testing
Number of subjects: 25
Study 7653319 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral marital therapy (BMT) with relapse prevention (RP)
Number of subjects: 74
Study 7653319 — intervention group
Group type: COMPARATOR
Intervention: Behavioral marital therapy (BMT) without relapse prevention (RP)
Number of subjects: 74
Study 2207995 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumide
Number of subjects: 110
Study 2207995 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study 7105797 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol (10 mg twice daily)
Number of subjects: 732
Study 31852482 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load blood flow restriction exercise (BFRE) for 12 weeks
Number of subjects: 22
Study 31852482 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise) for 12 weeks
Number of subjects: 22
Study 27838498 — intervention group
Group type: EXPERIMENTAL
Intervention: Video teleconferencing (VTC)
Number of subjects: 128
Study 27838498 — intervention group
Group type: COMPARATOR
Intervention: In-person (IP)
Number of subjects: 128
Study 26563197 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic niche resection
Number of subjects: 0
Study 26563197 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (Control)
Number of subjects: 0
Study 24941763 — intervention group
Group type: EXPERIMENTAL
Intervention: Low BTXA group (1 U/10(6) Cells)
Number of subjects: 0
Study 24941763 — intervention group
Group type: EXPERIMENTAL
Intervention: High BTXA group (2.5 U/10(6) Cells)
Number of subjects: 0
Study 24941763 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 24941763 — intervention group
Group type: EXPERIMENTAL
Intervention: BTXA groups (both low and high)
Number of subjects: 0
Study 22965588 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab injection
Number of subjects: 19
Study 22965588 — intervention group
Group type: COMPARATOR
Intervention: Sham injection (Control)
Number of subjects: 19
Study 19300235 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of trimethoprim‐sulfamethoxazole at urinary catheter removal
Number of subjects: 239
Study 19300235 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 239
Study 17179353 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 kVp
Number of subjects: 62
Study 17179353 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 kVp
Number of subjects: 62
Study 17179353 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp
Number of subjects: 62
Study 17179353 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 62
Study 15325937 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban infusion before percutaneous coronary intervention
Number of subjects: 0
Study 11563799 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory setting
Number of subjects: 39
Study 11563799 — intervention group
Group type: EXPERIMENTAL
Intervention: On-campus bar setting
Number of subjects: 39
Study 9781932 — intervention group
Group type: EXPERIMENTAL
Intervention: Saterinone
Number of subjects: 12
Study 9781932 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 12
Study 9781932 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside
Number of subjects: 12
Study 8091463 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) at 1 g per kg per day for 2 consecutive days each week for 4 weeks
Number of subjects: 12
Study 8091463 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline placebo administered according to the same schedule as IVIG
Number of subjects: 12
Study 3045553 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated-fat diet
Number of subjects: 10
Study 3045553 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate diet
Number of subjects: 10
Study 29759857 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of IV‐TXA at 3‐hour intervals (group C)
Number of subjects: 150
Study 28916599 — intervention group
Group type: EXPERIMENTAL
Intervention: DA+DCB
Number of subjects: 102
Study 28916599 — intervention group
Group type: COMPARATOR
Intervention: DCB
Number of subjects: 102
Study 26253488 — intervention group
Group type: EXPERIMENTAL
Intervention: SEQ-IMRT
Number of subjects: 122
Study 26253488 — intervention group
Group type: COMPARATOR
Intervention: SIB-IMRT
Number of subjects: 122
Study 23158592 — intervention group
Group type: EXPERIMENTAL
Intervention: Half volume group
Number of subjects: 80
Study 23158592 — intervention group
Group type: COMPARATOR
Intervention: Resting volume group
Number of subjects: 80
Study 21146270 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR <30 mL/min/1.73 m(2)
Number of subjects: 15336
Study 21146270 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR 30-44 mL/min/1.73 m(2)
Number of subjects: 15336
Study 21146270 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR 45-59 mL/min/1.73 m(2)
Number of subjects: 15336
Study 21146270 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR ≥75 mL/min/1.73 m(2)
Number of subjects: 15336
Study 21146270 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipstick-positive proteinuria
Number of subjects: 15336
Study 21146270 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR <30 mL/min/1.73 m(2) and dipstick-positive proteinuria
Number of subjects: 15336
Study 20633367 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency bilateral rTMS (20 trains of 10 Hz at 110% of the RMT, administered daily for 3 weeks)
Number of subjects: 20
Study 20633367 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 20
Study 16479736 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized asthma desensitization (previously specific immunotherapy, SIT)
Number of subjects: 1182
Study 16479736 — intervention group
Group type: COMPARATOR
Intervention: Usual medications (control group)
Number of subjects: 1182
Study 12207596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fluticasone propionate (FP) cream 0.05% (twice per week)
Number of subjects: 372
Study 12207596 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream/emollients
Number of subjects: 372
Study 10477967 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-sampling and mailing urine/vaginal flush samples to the laboratory
Number of subjects: 8909
Study 10477967 — intervention group
Group type: COMPARATOR
Intervention: Examination by a physician
Number of subjects: 8909
Study 8567611 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy adapted for sexually abused preschool children (CBT-SAP)
Number of subjects: 67
Study 8567611 — intervention group
Group type: COMPARATOR
Intervention: Nondirective supportive therapy (NST)
Number of subjects: 67
Study 1858672 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepridil (200 to 400 mg/day)
Number of subjects: 86
Study 1858672 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem (median 360 mg/day)
Number of subjects: 86
Study 1858672 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepridil
Number of subjects: 86
Study 1858672 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 86
Study 6337083 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1.6 gm daily)
Number of subjects: 51
Study 6337083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 30874782 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity intervention (Arm 2)
Number of subjects: 6000
Study 30874782 — intervention group
Group type: COMPARATOR
Intervention: High-intensity intervention (Arm 3)
Number of subjects: 6000
Study 30874782 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity intervention (Arm 1)
Number of subjects: 6000
Study 30062633 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing Injection (XBJ)
Number of subjects: 50
Study 30062633 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 50
Study 27440003 — intervention group
Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 8598
Study 24566584 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR)
Number of subjects: 4685
Study 24566584 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 4685
Study 24566584 — intervention group
Group type: COMPARATOR
Intervention: Patient Mailing
Number of subjects: 4685
Study 22251061 — intervention group
Group type: EXPERIMENTAL
Intervention: OptiNose powder device (Opt‐Powder)
Number of subjects: 7
Study 22251061 — intervention group
Group type: COMPARATOR
Intervention: Traditional liquid spray pump (Spray)
Number of subjects: 7
Study 19935106 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen artery embolization (SAE)
Number of subjects: 16
Study 19935106 — intervention group
Group type: COMPARATOR
Intervention: Control (nonembolized patients)
Number of subjects: 16
Study 16438474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole (0.25-4.0 mg once daily, 1 to 3 hours before bedtime)
Number of subjects: 381
Study 16438474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 381
Study 16438474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study 12695313 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 7152
Study 12695313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7152
Study 11204324 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation with impulsive magnetic field therapy
Number of subjects: 54
Study 11204324 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation without impulsive magnetic field therapy
Number of subjects: 54
Study 8823858 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal phenylephrine drops
Number of subjects: 44
Study 8823858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 1408294 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil by PKPCA
Number of subjects: 0
Study 1408294 — intervention group
Group type: COMPARATOR
Intervention: Morphine by PKPCA
Number of subjects: 0
Study 2416161 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA treatment
Number of subjects: 29
Study 2416161 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment
Number of subjects: 29
Study 30600223 — intervention group
Group type: EXPERIMENTAL
Intervention: Brochures
Number of subjects: 62
Study 30600223 — intervention group
Group type: EXPERIMENTAL
Intervention: Scripted conversation
Number of subjects: 62
Study 30600223 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐minute video
Number of subjects: 62
Study 29202611 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 1323
Study 29202611 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 1323
Study 29202611 — intervention group
Group type: EXPERIMENTAL
Intervention: High Aurora A expression
Number of subjects: 1323
Study 29202611 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Aurora A expression
Number of subjects: 1323
Study 27611985 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO) 100 units/kg, subcutaneous injection on days 1, 3, 6, 9, and 12
Number of subjects: 159
Study 27611985 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 159
Study 27611985 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO)
Number of subjects: 159
Study 24614619 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA
Number of subjects: 60
Study 24614619 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 60
Study 23088620 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 267
Study 23088620 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 267
Study 20861451 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins B(12), B(6), and folic acid supplementation
Number of subjects: 299
Study 20861451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 18570009 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with specially processed cereals (SPC)
Number of subjects: 82
Study 18570009 — intervention group
Group type: COMPARATOR
Intervention: Placebo diet
Number of subjects: 82
Study 16206587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 147
Study 12296922 — intervention group
Group type: EXPERIMENTAL
Intervention: Small SJM standard valves (19 mm or 21 mm)
Number of subjects: 68
Study 12296922 — intervention group
Group type: EXPERIMENTAL
Intervention: Small SJM Hemodynamic Plus (HP) valves
Number of subjects: 68
Study 12296922 — intervention group
Group type: COMPARATOR
Intervention: Large-size SJM standard valve (23 mm or larger)
Number of subjects: 68
Study 12296922 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (small aortic annulus)
Number of subjects: 68
Study 12296922 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (large aortic annulus)
Number of subjects: 68
Study 10522284 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-controlled use of physical assistance devices (ski poles)
Number of subjects: 2
Study 10522284 — intervention group
Group type: COMPARATOR
Intervention: Yoked group (no influence on pole/no-pole schedule)
Number of subjects: 2
Study 8770779 — intervention group
Group type: EXPERIMENTAL
Intervention: Earplugs
Number of subjects: 15
Study 8770779 — intervention group
Group type: EXPERIMENTAL
Intervention: Music tape
Number of subjects: 15
Study 8770779 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU environmental noise tape
Number of subjects: 15
Study 1785361 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment (low-salt diet 70 to 90 mEq of Na per day, stopping diuretics and laxatives, elastic stockings) + carbidopa/levodopa 25/100 (3 tabs/day) + captopril 6.25 mg q 8 h
Number of subjects: 10
Study 1785361 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (low-salt diet 70 to 90 mEq of Na per day, stopping diuretics and laxatives, elastic stockings)
Number of subjects: 10
Study 1785361 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 10
Study 1785361 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with IE
Number of subjects: 10
Study 6783363 — intervention group
Group type: EXPERIMENTAL
Intervention: Noxytiolin instillation during radical radiotherapy
Number of subjects: 242
Study 6783363 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Noxytiolin) during radical radiotherapy
Number of subjects: 242
Study 30975143 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (600 mg, twice daily for 12 months)
Number of subjects: 161
Study 30975143 — intervention group
Group type: COMPARATOR
Intervention: Control (on-demand treatment)
Number of subjects: 161